Harriet, of Oxford, speaks about taking part in the Novavax COVID-19 vaccine trial, which was found to be 89.3% effective.
This video is published by the NIHR Clinical Research Network Thames Valley and South Midlands, which supports the delivery of research in Berkshire, Buckinghamshire, Oxfordshire and Milton Keynes.
